GIACOBELLO SCOTT M. (Chief Financial Officer) sold 8.5% of their position (2.59K shares) of WHITEHAWK THERAPEUTICS, INC. on the open market
Open‑market sale worth $8.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/10/2026ACC: 0001754154-26-000002
Officer· Chief Financial Officer
Since Nov 2021
-2.59K
Net shares
Net seller
$8.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.75K acquired · 9.34K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.75K
Price / share
—
Trade value
—
% of position
28.2%
3/1/2026
23.94K→30.69K
Common Stock
Direct
Shares
−2.59K
Price / share
$3.31
Trade value
$8.59K
% of position
8.5%
3/2/2026
30.69K→28.10K
Total
Net shares
+4.16K
Net value
-$8.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2026 | M · Option Exercise | +6.75K | — | — | 28.2% | 23.94K | 30.69K |
| Common Stock Direct | 3/2/2026 | S · Sale | −2.59K | $3.31 | $8.59K | 8.5% | 30.69K | 28.10K |
| Total | +4.16K | -$8.59K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
6.75K shares
Shares
−6.75K
Strike price
Held after
13.50K
Exercisable
—
3/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock6.75K shares | 3/1/2026 | M · Option Exercise | −6.75K | — | 13.50K |